Polyvinyl alcohol—gelatin patches were developed and salicylic acid was incorporated at different stages of preparation of the patches. The patches were characterized by Fourier transform infrared (FTIR) spectroscopy, X-ray diffraction (XRD), differential scanning calorimetry, tensile strength test, and scanning electron microscopy. The release patterns of the drug from the patches were also studied. The FTIR spectra of the blank patch indicated complete esterification of the free carboxylic groups of gelatin. The XRD studies indicated a crystalline form of the drug entrapped in the patches. Release of the drug from the patches followed Higuchian/Fickian kinetics indicating a diffusion-controlled release process.
Chong, S. and Fung, H.L. (1989). Transdermal Drug Delivery Systems: Pharmacokinetics, Clinical Efficacy, and Tolerance Development, In: Hadgraft, J. and Guy, R.H. (eds), Transdermal Drug Delivery: Developmental Issues and Research Initiatives, p. 135-135, Marcel Dekker, New York, NY .
2.
Audet, M.C. (2001). Evaluation of Contraceptive Efficacy and Cycle Control of a Transdermal Contraceptive Patch vs. an Oral Contraceptive: A Randomized Controlled Trial , JAMA, 285(18): 2347—2354 .
3.
(2001). Retail and Provider Perspective, IMS Health.
4.
Chien, Y.W. (1992). Novel Drug Delivery Systems, 2nd edn, Marcel Dekker, Inc., New York .
5.
Chasen, M. and Langer, R. (1997). Biodegradable Polymers as Drug Delivery Systems, Marcel Dekker, New York .
6.
Cleary, G.W. (1993). Transdermal Delivery Systems: A Medical Rationale, In: Shah, V.P. and Maibach, H.I. (eds), Topical Drug Bioavailability, Bioequivalance and Penetration, pp. 17—68, Plenum Press, New York .
7.
Panchagnula, R. , Stemmer, K. and Ritschel, W.A. (1997). Animal Models for Transdermal Drug Delivery , Methods Find. Exp. Clin. Pharmacol., 19: 335—341 .
8.
Janne, P.A. and Mayer, R.J. (2000). Chemoprevention of Colorectal Cancer , N. Engl. J. Med., 342: 1960—1968 .
9.
Bair, W.B. , Hart, N. , Einspahr, J. , Liu, G. , Dong, Z. , Alberts, D. and Bowden, G.T. (December 2002). Inhibitory Effects of Sodium Salicylate and Acetylsalicylic Acid on UVB-induced Mouse Skin Carcinogenesis , Cancer Epidemiol. Biomarkers Prev., 11(12): 1645—1652 .
10.
Laneuville, O. , Breuer, D.K. , Dewitt, D.L. , Hla, T. , Funk, C.D. and Smith, W.L. (1994). Differential Inhibition of Human Prostaglandin Endoperoxide H Synthases-1 and -2 by Nonsteroidal Anti-inflammatory Drugs , J. Pharmacol. Exp. Ther., 271(2): 927—934 .
11.
Banoczy, J. , Squier, C.A. and Kremer, M. (2003). The Permeability of Oral Leukoplakia , Eur. J. Oral. Sci., 111(4): 312—315 .
12.
Panje, W.R. (1981). Regression of Head and Neck Carcinoma with a Prostaglandin-synthesis Inhibitor , Arch. Otolaryngol., 107(11): 658—663 .
13.
Perkins, T.M. and Shklar, G. (1982). Delay in Hamster Buccal Pouch Carcinogenesis by Aspirin and Indomethacin , Oral Surg. Oral Med. Oral Pathol., 53(2): 170—178 .
14.
Cornwall, H. , Odukoya, O. and Shklar, G. (1983). Oral Mucosal Tumor Inhibition by Ibuprofen , J. Oral Maxillofac. Surg., 41(12): 795—800 .
15.
Balkwill, F. and Mantovani, A. (2001). Inflammation and Cancer: Back to Virchow?Lancet, 357(2): 539—545 .
16.
Davies, M. and Marks, R. (1976). Studies on the Effect of Salicylic Acid on Normal Skin , Br. J. Dermatol., 95(1): 187—192 .
17.
Morgan, G. (7th February 2004). An Aspirin a Day, New Scientist, 36—39.
18.
Rao, C.V. and Reddy, B.S. (2004). NSAIDs and Chemoprevention , Curr. Cancer Drug Targets, 4(1): 29—42 .
19.
Murono, S. , Yoshizaki, T. , Sato, H. , Takeshita, H. , Furukawa, M. and Pagano, J.S. (2000). Aspirin Inhibits Tumor Cell Invasiveness by Epstein-Barr Virus Latent Membrane Protein 1 Through Suppression of Matrix Metalloproteinase-9 Expression , Cancer Res., 60(9): 2555—2561 .
20.
Tsai, J. , Chuang, S. , Hsu, M. and Sheu, H. (1999). Distribution of Salicylic Acid in Human Stratum Corneum Following Topical Application in vivo: A Comparison of Six Different Formulations , Int. J. Pharm., 188(3): 145—153 .
21.
22.
Horii, F. , Hu, S. , Ito, T. , Odani, H. and Kitamaru, R. (1992). Cross Polarization/Magic Angle Spinning 13C n.m.r. Study of Solid Structure and Hydrogen Bonding of Poly(vinyl alcohol) Films with Different Tacticities , Polymer, 33(9): 2299—2308 .
23.
Peppas, N.A. and Merrill, E.W. (1997). Development of Semicrystalline Poly Vinyl Alcohol Hydrogels for Biomedical Application , J. Biomed. Mater. Res., 11(4): 423—434 .
24.
Oakenfulland, D. and Scott, A. (2003). Gelatin Gels in Deuterium Oxide , Food Hydrocoll., 17(2): 207—210 .
25.
Bigi, A. , Panzavolta, S. and Rubini, K. (2004). Relationship between Triple-helix Content and Mechanical Properties of Gelatin Films , Biomaterials, 25(7): 5675—5680 .
26.
Babin, H. and Dickinson, E. (2001). Influence of Transglutamase Treatment on the Thermoreversible Gelation of Gelatin , Food Hydrocoll., 15(1): 271—276 .
27.
Wu, S. (1973). Polar and Nonpolar Interactions in Adhesion , J. Adhes., 5(1): 39—46 .
28.
Schultz, J. and Carre, A. (1987). Theory of Adhesion based on Pseudo-Crosslink Model , J. Adhes. Soc. Jpn., 23(2): 407—414 .
29.
Ehrburger, P. and Donnet, J.B. (1980). Interphase in Composite Materials , Philos. Trans. R. Sco. London, A249(1): 495-495 .
30.
Yosomiya, R. , Morimoto, K. , Nakajima, A. , Ikada, Y. and Suzuki, T.Adhesion and Bonding in Composite, Marcel Dekker, New York .
31.
Eisele, Ulrich (1990). Introduction to Polymer Physics, pp. 91—95, Springer-Verlag, Berlin .
32.
Torres, D. , Garcia-Encin, G. , Seij, B. and Vila Jat, J.L. (1995). Formulation and in vitro Evaluation of HPMCP-microencapsulated Drug-resin Complexes for Sustained Release of Diclofenac , Int. J. Pharm., 121(1): 239—243 .
33.
Nokhodchi, A. , Farid, D.J. , Najafi, M. and Adrangui, M. (1997). Studies on Controlled-release Formulations of Diclofenac Sodium , Drug Dev. Ind. Pharm., 23: 1019—1023 .
34.
Rani, M. and Mishra, B. (2001). Effect of Admixed Polymers on Diclofenac Sodium Release from Matrix Tablets , Pharm. Pharmacol. Lett., 11: 76—78 .
